BLTI Related Corporate News
-
BIOLASE Technology (BLTI) Files Patent Infringement Suit in Germany
-
BIOLASE Technology (BLTI) Completes Waterlase Acquisition with Henry Schein (HSIC)
-
BIOLASE (BLTI) Approved to Sell Waterlase iPlus in Russia
-
BIOLASE (BLTI) Receives U.S. Patemt Entitled 'Methods for Treating Eye Conditions'
-
BIOLASE (BLTI) Approved to Sell Waterlase iPlus in Canada
-
BIOLASE (BLTI) Expands Offerings to German Market
-
BIOLASE (BLTI) Receives CE Mark for Waterlase iPlus System
-
BIOLASE Tech (BLTI) Issued Two New Electromagnetic Energy U.S. Patents
-
Spectrum Pharmaceuticals (SPPI) appoints Scott as Acting CFO
-
Biolase (BLTI) Announces 30% Increase to N.A. Sales Team
-
BIOLASE Tech. (BLTI) Completes Corporate-Wide Restructuring; To Be Profitable in Q410
-
Biolase (BLTI) Announces Definitive Pact with Henry Schein (HSIC); Deal Changes to Non-Exclusive Distribution
-
BIOLASE Tech (BLTI) Announces Henry Schien (HSIC) To Become Non-Exclusive Distributor in N.A.
-
Biolase Technology (BLTI) trading halted with news pending
-
BIOLASE Tech. (BLTI) Receives Deficiency Letter from Nasdaq
-
BIOLASE Technology (BLTI) Announces Headcount Reduction, CEO to Assume CFO Responsibilities on Interim Basis
-
BIOLASE Tech (BLTI) Receives Approval for iLase Usage Throughout Canada
-
BIOLASE Tech (BLTI) Announces $5M Secured Debt Facility with MidCap Financial
-
BIOLASE (BLTI) Signs License Agreement with Proctor & Gamble (PG)
-
BIOLASE Tech (BLTI) Announces Discus Dental and Zap Lasers Have Filed Amendedd Complaint in Patent Suit
-
BIOLASE Technology (BLTI) Awarded Patent for New Teeth Whitening Handpiece
-
BIOLASE Tech (BLTI) Receives 501(k) Clearance from U.S. FDA for iLase Diode Laser
-
BIOLASE Tech (BLTI) Amends Licensing Agreement with Henry Schein (HSIC); Updates Q409 and FY10 Guidance
-
BIOLASE Technology (BLTI) Granted Approval in People's Republic of China to Sell Waterlase Dental Laser Systems
-
BIOLASE (BLTI) Announces FDA 510(K) Clearance of Its ezlase Diode Laser for Pain Therapy & Relief
-
BIOLASE (BLTI) and NLT Announce Settlement Agreement
-
BIOLASE Technology (BLTI) and Henry Schein (HSIC) Renew and Expand Licensing/Distribution Agreement; BLTI Announces Additional Cost Reductions
-
BIOLASE Technology (BLTI) Guides Below for Q4 and FY08 Revenues; Cuts Workforce by 20%
-
S&P Announces Changes to US Indices: AMZN for MER, SCG for MER, OHI for SCG, COST for WB, OI for WB, FLIR for NCC, VLY for FLIR, AMSF for FED, ATU for BLTI, ACAP for MNC, INDB for LBY, IN for SINT
-
BIOLASE (BLTI) Announces FDA 510(k) Clearance of Its Waterlase(R) and Waterlase(R) MD Laser Systems for Root Canal Disinfection
-
BIOLASE Technology (BLTI) Comments on Recent Market Activity
-
BIOLASE Technology (BLTI) Announces Partnership with Proctor & Gamble (PG)
-
BLTI to delay 10-K filing
-
BLTI Gains U.S. and International License to Presbyopia Patents
-
BLTI Granted New European Patent
Back to BLTI Stock Lookup
